Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;80(4):336-343.
doi: 10.4046/trd.2017.0049. Epub 2017 Sep 1.

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea

Doosoo Jeon  1
Affiliations
Review

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea

Doosoo Jeon. Tuberc Respir Dis (Seoul). 2017 Oct.

Abstract

Despite progress made in tuberculosis control worldwide, the disease burden and treatment outcome of multidrug-resistant tuberculosis (MDR-TB) patients have remained virtually unchanged. In 2016, the World Health Organization released new guidelines for the management of MDR-TB. The guidelines are intended to improve detection rate and treatment outcome for MDR-TB through novel, rapid molecular testing and shorter treatment regimens. Key changes include the introduction of a new, shorter MDR-TB treatment regimen, a new classification of medicines and updated recommendations for the conventional MDR-TB regimen. This paper will review these key changes and discuss the potential issues with regard to the implementation of these guidelines in South Korea.

Keywords: Guideline; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. World Health Organization. Global tuberculosis report 2016. WHO/HTM/TB/2016.13 [Internet] Geneva: World Health Organization; 2016. [cited 2017 May 1]. Available from: http://www.who.int/tb/publications/global_report/en.
    1. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994–2004. Int J Tuberc Lung Dis. 2007;11:571–576. - PubMed
    1. Park YS, Hong SJ, Boo YK, Hwang ES, Kim HJ, Cho SH, et al. The national status of tuberculosis using nationwide medical records survey of patients with tuberculosis in Korea. Tuberc Respir Dis. 2012;73:48–55. - PMC - PubMed
    1. Korea Centers for Disease Control & Prevention. Annual report on the notified tuberculosis patients in Korea 2016 [Internet] Cheongju: Korea Centers for Disease Control & Prevention; 2017. [cited 2017 May 1]. Available from: http://tbzero.cdc.go.kr.
    1. Kim HJ, Hong YP, Kim SJ, Lew WJ, Lee EG. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic. Int J Tuberc Lung Dis. 2001;5:1129–1136. - PubMed